Nationwide surveillance of antimicrobial susceptibility patterns of pathogens isolated from surgical site infections (SSI) in Japan

Journal of Infection and Chemotherapy

Volumn 18, Issue 6, 2012, Pages 816-826

  Takesue, Yoshio ^a,b,ac   Watanabe, Akira ^a   Hanaki, Hideaki ^c   Kusachi, Shinya ^a,d   Matsumoto, Tetsuro ^a   Iwamoto, Aikichi ^a   Totsuka, Kyoichi ^a   Sunakawa, Keisuke ^a   Yagisawa, Morimasa ^a   Sato, Junko ^a   Oguri, Toyoko ^a   Nakanishi, Kunio ^a   Sumiyama, Yoshinobu ^e,f   Kitagawa, Yuko ^e,g   Wakabayashi, Go ^h   Koyama, Isamu ⁱ   Yanaga, Katsuhiko ^j   Konishi, Toshiro ^k   Fukushima, Ryoji ^l   Seki, Shiko ^m   Imai, Shun ⁿ   Shintani, Tsunehiro ^o   Tsukada, Hiroki ^p   Tsukada, Kazuhiro ^q   Omura, Kenji ^r   Mikamo, Hiroshige ^s   Takeyama, Hiromitsu ^t   Kusunoki, Masato ^u   Kubo, Shoji ^v   Shimizu, Junzo ^w   Hirai, Toshihiro ^x   Ohge, Hiroki ^y   Kadowaki, Akio ^z   Okamoto, Kohji ^aa   Yanagihara, Katsunori ^ab   more..

^a Surveillance Committee of JSC JAID and JSCM   (Japan)

^b HYOGO COLLEGE OF MEDICINE HOSPITAL   (Japan)

^c KITASATO UNIVERSITY   (Japan)

^d TOHO UNIVERSITY OHASHI MEDICAL CENTER   (Japan)

^e Japan Society for Surgical Infection   (Japan)

^f TOHO UNIVERSITY   (Japan)

^g KEIO UNIVERSITY HOSPITAL   (Japan)

^h IWATE MEDICAL UNIVERSITY   (Japan)

ⁱ SAITAMA MEDICAL UNIVERSITY   (Japan)

^j JIKEI UNIVERSITY HOSPITAL   (Japan)

^k Nippon Telegraph and Telephone Corporation Medical Center Tokyo   (Japan)

^l TEIKYO UNIVERSITY HOSPITAL   (Japan)

^m NATIONAL HOSPITAL ORGANIZATION TOKYO MEDICAL CENTER   (Japan)

ⁿ Hiratsuka City Hospital   (Japan)

^o SHIZUOKA RED CROSS HOSPITAL   (Japan)

^p NIIGATA CITY GENERAL HOSPITAL   (Japan)

^q TOYAMA UNIVERSITY HOSPITAL   (Japan)

^r Koseiren Takaoka Hospital   (Japan)

^s AICHI MEDICAL UNIVERSITY HOSPITAL   (Japan)

^t NAGOYA CITY UNIVERSITY HOSPITAL   (Japan)

^u MIE UNIVERSITY HOSPITAL   (Japan)

^v OSAKA CITY UNIVERSITY HOSPITAL   (Japan)

^w TOYONAKA MUNICIPAL HOSPITAL   (Japan)

^x KAWASAKI MEDICAL SCHOOL   (Japan)

^y HIROSHIMA UNIVERSITY HOSPITAL   (Japan)

^z SAN IN ROSAI HOSPITAL   (Japan)

^aa UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^ab NAGASAKI UNIVERSITY HOSPITAL   (Japan)

^ac HYOGO COLLEGE OF MEDICINE   (Japan)

more..

Author keywords

Antibiotic susceptibility; Bacteroides fragilis group; Surgical site infections; Surveillance

Indexed keywords

AMPICILLIN; BIAPENEM; CEFAZOLIN; CEFEPIME; CEFMETAZOLE; CEFTAZIDIME; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; DAPTOMYCIN; DORIPENEM; ERYTHROMYCIN; GENTAMICIN; HABEKACIN; IMIPENEM; LEVOFLOXACIN; LINEZOLID; MEROPENEM; METRONIDAZOLE; MINOCYCLINE; OXACILLIN; PANIPENEM; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; SULTAMICILLIN; TEICOPLANIN; VANCOMYCIN; ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BACTEROIDES FRAGILIS; BACTEROIDES THETAIOTAOMICRON; ENTEROBACTER CLOACAE; ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING KLEBSIELLA PNEUMONIAE; HEALTH SURVEY; HUMAN; JAPAN; MAJOR CLINICAL STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PREVALENCE; PSEUDOMONAS AERUGINOSA; SURGICAL INFECTION; TREND STUDY; BACTERIUM; DRUG EFFECT; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY;

ANTI-BACTERIAL AGENTS; BACTERIA; DRUG RESISTANCE, BACTERIAL; HUMANS; JAPAN; MICROBIAL SENSITIVITY TESTS; SURGICAL WOUND INFECTION;

EID: 84880443113     PISSN: 1341321X     EISSN: 14377780     Source Type: Journal    
DOI: 10.1007/s10156-012-0509-1     Document Type: Article

References (23)

1. http://www.kankyokansen.org:jhais-ssi-symmary.pdf. Accessed 10 Jan 2012.
2. Anthony T, Long J, Hynan LS, Sarosi GA Jr, Nwariaku F, Huth J, et al. Surgical complications exert a lasting effect on disease-specific health-related quality of life for patients with colorectal cancer. Surgery (St. Louis). 2003;134:119-25. (Pubitemid 37070328)
3. Astagneau P, Rioux C, Golliot F, Brucker G. INCISCO Network Study Group: morbidity and mortality associated with surgical site infections: results from the 1997-1999 INCISO surveillance. J Hosp Infect. 2001;48:267-74. (Pubitemid 32694573)
4. Dimick JB, Chen SL, Taheri PA, Henderson WG, Khuri SF, Campbell DA Jr. Hospital costs associated with surgical complications: a report from the private-sector National Surgical Quality Improvement Program. J Am Coll Surg. 2004;199:531-7. (Pubitemid 39420202)
5. Kirkland KB, Briggs JP, Trivette S, Wilkinson WE, Sedon DJ. The impact of surgical-site infection in the 1990s: attribute mortality, excess length of hospitalization, and extra costs. Infect Control Hosp Epidemiol. 1999;20:725-30.
6. National Nosocomial Infections Surveillance System. National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control. 2004;32:470-85. (Pubitemid 39574472)
7. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial disk susceptibility tests; approved standards, 9th edn. M2-M9. Wayne: Clinical and Laboratory Standards Institute; 2006.
8. Clinical and Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard, 8th edn. M7-A8. Wayne: Clinical and Laboratory Standards Institute; 2009.
9. Hanaki H, Kubo R, Nakano T, Kurihara M, Sunagawa K. Characterization of HMRZ-86. a novel chromogenic cephalosporin for the detection of extended-spectrum beta-lactamases. J Antimicrob Chemother. 2004;53:888-9. (Pubitemid 38660301)
10. Colodner R, Rezik B, Gal V, Yamazaki H, Hanaki H, Kubo R. Evaluation of a novel kit for the rapid detection of extended-spectrum beta-lactamase. Eur J Clin Microb Infect Dis. 2006;25:49-51. (Pubitemid 43207331)
11. Schnüriger B, Inaba K, Eberle BM, Wu T, Talving P, Bukur M, et al. Microbiological profile and antimicrobial susceptibility in surgical site infections following hollow viscus injury. J Gastrointest Surg. 2010;14:1304-10.
12. Brook I. Antimicrobial treatment of anaerobic infections. Expert Opin. 2011;12:1691-707.
13. Goldstein EJ. Intra-abdominal anaerobic infections: bacteriology and therapeutic potential of newer antimicrobial carbapenem, fluoroquinolone, and desfluoroquinolone therapeutic agents. Clin Infect Dis. 2002;35(suppl 1):S106-11.
14. Snydman DR, Jacobus NV, McDermott LA, Golan Y, Hecht DW, Goldstein EJC, et al. Lessons learned from the anaerobe survey: historical perspective and review of the most recent data (2005-2007). Clin Infect Dis. 2010;50(suppl 1):S26-33.
15. Montravers P, Lepape A, Dubreuil L, Gauzit R, Pean Y, Benchimol D, et al. Clinical and microbiological profiles of community-acquired and nosocomial intra-abdominal infections: results of the French prospective, observational EBIIA study. J Antimicrob Chemother. 2009;63:785-94.
16. Solomkin JS, Mazuski JE, Bradley JS, Rodvold KA, Goldstein EJC, Baron EJ, et al. Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Disease Society of America. Clin Infect Dis. 2010;50:133-64.
17. Nakamura T, Komatsu M, Yamasaki K, Fukuda S, Miyamoto Y, Higuchi T, et al. Epidemiology of Escherichia coli, Klebsiella species, and Proteus mirabilis strains producing extended-spectrum β-lactamases from clinical samples in the Kinki Region of Japan. Am J Clin Pathol. 2012;137:620-6.
18. Takesue Y, Nakajima K, Takahashi Y, Ichiki K, Ishihara M, Wada Y, et al. Clinical characteristics of vancomycin minimum inhibitory concentration of 2 μg/ml methicillin-resistant Staphylococcus aureus strains isolated from patients with bacteremia. J Infect Chemother. 2011;17:52-7.
19. Jones RN. Microbial etiologies of hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia. Clin Infect Dis. 2010;51(suppl 1):S81-7.
20. Mathai D, Jones RN, SENTRY Participant Group North America. Epidemiology and frequency of resistance among pathogens causing urinary tract infections in 1,510 hospitalized patients: a report from the SENTRY Antimicrobial Surveillance Program (North America). Diagn Microbiol Infect Dis. 2011;40:129-36.
21. Mentzelopoulos SD, Pratikaki M, Platsouka E, Kraniotani H, Zervakis D, Koufsoukou A, et al. Prolonged use of carbapenems and colistin predisposes to ventilator-associated pneumonia by pandrug-resistant Pseudomonas aeruginosa. Intensive Care Med. 2007;33:1524-32. (Pubitemid 47312466)
22. Kusachi S, Sumiyama Y, Arima Y, Yoshida Y, Tanaka H, Nakamura Y, et al. Isolated bacteria and drug susceptibility associated with the course of surgical site infections. J Infect Chemother. 2007;13:166-71. (Pubitemid 47012500)
23. Stevens DL, Bisno AL, Chambers HF, Everett ED, Dellinger P, Goldstein EJ, et al. Practice guidelines for the diagnosis and management of skin and soft-tissue infections. Clin Infect Dis. 2005;41:1373-406. (Pubitemid 41581713)